113 related articles for article (PubMed ID: 15162350)
1. Constitutive expression of interleukin-18 in head and neck squamous carcinoma cells.
Martone T; Bellone G; Pagano M; Beatrice F; Palonta F; Emanuelli G; Cortesina G
Head Neck; 2004 Jun; 26(6):494-503. PubMed ID: 15162350
[TBL] [Abstract][Full Text] [Related]
2. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
[TBL] [Abstract][Full Text] [Related]
3. Correlations between thymidylate synthase expression and chemosensitivity to 5-fluorouracil, cell proliferation and clinical outcome in head and neck squamous cell carcinoma.
Yasumatsu R; Nakashima T; Uryu H; Ayada T; Wakasaki T; Kogo R; Masuda M; Fukushima M; Komune S
Chemotherapy; 2009; 55(1):36-41. PubMed ID: 19023200
[TBL] [Abstract][Full Text] [Related]
4. Expression of IL-18 in patients with head and neck squamous cell carcinoma.
Riedel F; Adam S; Feick P; Haas S; Götte K; Hörmann K;
Int J Mol Med; 2004 Feb; 13(2):267-72. PubMed ID: 14719133
[TBL] [Abstract][Full Text] [Related]
5. Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Ikappa beta kinase.
Cohen AN; Veena MS; Srivatsan ES; Wang MB
Arch Otolaryngol Head Neck Surg; 2009 Feb; 135(2):190-7. PubMed ID: 19221248
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
[TBL] [Abstract][Full Text] [Related]
7. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratins 6 and 16 are frequently expressed in head and neck squamous cell carcinoma cell lines and fresh biopsies.
Sesterhenn AM; Mandic R; Dünne AA; Werner JA
Anticancer Res; 2005; 25(4):2675-80. PubMed ID: 16080511
[TBL] [Abstract][Full Text] [Related]
9. Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens.
Woods KV; El-Naggar A; Clayman GL; Grimm EA
Cancer Res; 1998 Jul; 58(14):3132-41. PubMed ID: 9679981
[TBL] [Abstract][Full Text] [Related]
10. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapeutic alteration of VEGF, PDGF and PDGFRα/β expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Aderhold C; Umbreit C; Faber A; Sauter A; Sommer JU; Birk R; Erben P; Hofheinz RD; Stern-Straeter J; Hörmann K; Schultz JD
Anticancer Res; 2013 May; 33(5):1951-61. PubMed ID: 23645743
[TBL] [Abstract][Full Text] [Related]
12. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
Bran B; Bran G; Hörmann K; Riedel F
Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
[TBL] [Abstract][Full Text] [Related]
13. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
[TBL] [Abstract][Full Text] [Related]
14. Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.
Myers JN; Yasumura S; Suminami Y; Hirabayashi H; Lin Wc; Johnson JT; Lotze MT; Whiteside TL
Clin Cancer Res; 1996 Jan; 2(1):127-35. PubMed ID: 9816099
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of RAD17 in head and neck cancer.
Zhao M; Begum S; Ha PK; Westra W; Califano J
Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
[TBL] [Abstract][Full Text] [Related]
16. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
17. Secretion of tumor-promoting and immune suppressive cytokines by cell lines of head and neck squamous cell carcinoma.
Pries R; Thiel A; Brocks C; Wollenberg B
In Vivo; 2006; 20(1):45-8. PubMed ID: 16433027
[TBL] [Abstract][Full Text] [Related]
18. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
19. Presence of membrane-bound TGF-beta1 and its regulation by IL-2-activated immune cell-derived IFN-gamma in head and neck squamous cell carcinoma cell lines.
Ahn YO; Lee JC; Sung MW; Heo DS
J Immunol; 2009 May; 182(10):6114-20. PubMed ID: 19414763
[TBL] [Abstract][Full Text] [Related]
20. The role of ZEB1 in the inflammation-induced promotion of EMT in HNSCC.
Dohadwala M; Wang G; Heinrich E; Luo J; Lau O; Shih H; Munaim Q; Lee G; Hong L; Lai C; Abemayor E; Fishbein MC; Elashoff DA; Dubinett SM; St John MA
Otolaryngol Head Neck Surg; 2010 May; 142(5):753-9. PubMed ID: 20416468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
